Description

Pfizer’s competitive independent medical education program supports initiatives addressing gaps in the diagnosis, treatment, and long-term management of hemophilia in Saudi Arabia. It aims to improve healthcare professionals’ knowledge, competencies, and clinical practice by strengthening treatment guideline implementation, understanding of referral and care pathways across hemophilia treatment centers, and awareness of treatment advances.

Supported approaches include educational outreach, hematology staff education in remote hospitals, grand rounds, training courses, webinars, adapted educational resources, and digital content. Resources may address the needs of hematologists, pediatric hematologists, orthopedic specialists, pharmacists, nurses, physiotherapists, radiologists, family physicians, and other professionals involved in hemophilia care. Proposals must include innovative dissemination plans and outcomes assessment addressing knowledge, behavioral change, application of learning, or barriers to practice. Clinical research and education primarily for patients or the public are outside scope.